children
bear
heaviest
burden
viral
respiratori
ill
studi
use
viral
cultur
estim
develop
countri
infant
preschool
children
experi
mean
viral
infect
annual
schoolag
children
adolesc
experi
ill
annual
limit
sensit
cultur
method
certainli
underestim
although
mani
viral
infect
limit
upper
respiratori
tract
viral
infect
lower
respiratori
tract
caus
enorm
diseas
burden
children
recent
role
respiratori
virus
seriou
lower
respiratori
tract
infect
lrti
older
adult
begun
appreci
although
articl
focus
infect
children
mani
issu
appli
older
adult
syndrom
lrti
children
includ
bronchiol
exacerb
asthma
wheez
croup
pneumonia
although
work
definit
exist
overlap
among
syndrom
although
respiratori
virus
strongli
associ
specif
syndrom
mani
virus
shown
caus
syndrom
tabl
often
difficult
differenti
viral
bacteri
pneumonia
children
seven
virus
consid
usual
suspect
lrti
sought
mani
studi
respiratori
syncyti
viru
rsv
influenza
b
parainfluenza
adenoviru
past
decad
least
new
virus
associ
respiratori
infect
identifi
includ
human
metapneumoviru
hmpv
sever
acut
respiratori
syndrom
coronaviru
human
coronaviru
parainfluenza
bocaviru
virus
respons
larg
proport
lrti
children
antibiot
often
prescrib
viral
ill
addit
viral
infect
caus
major
febril
episod
infant
month
age
howev
inabl
accur
identifi
minor
infant
seriou
bacteri
infect
major
febril
infant
hospit
receiv
antibiot
exist
viral
diagnost
enzym
immunoassaybas
rapid
test
limit
sensit
detect
influenza
rsv
case
direct
fluoresc
antibodi
detect
shell
vial
cultur
requir
sophist
virolog
laboratori
furthermor
sever
newer
pathogen
grow
well
cultur
better
diagnost
test
establish
caus
lrti
children
potenti
reduc
overal
antibiot
use
improv
target
use
antibiot
addit
rapid
identif
viral
infect
help
control
nosocomi
transmiss
studi
use
current
approv
rapid
test
direct
fluoresc
antibodi
test
despit
limit
method
alreadi
demonstr
improv
clinic
practic
bronchiol
diseas
children
year
age
character
acut
inflamm
edema
necrosi
epitheli
cell
line
small
airway
increas
mucu
product
lead
bronchospasm
wheez
hyperexpans
lung
hypoxia
bronchiol
caus
hospit
infant
year
age
annual
infant
hospit
bronchiol
annual
rsv
common
caus
bronchiol
detect
case
howev
virus
caus
bronchiol
clinic
indistinguish
rsvinduc
diseas
includ
parainfluenza
viru
adenoviru
rhinoviru
hmpv
coronaviru
bocaviru
polymeras
chain
reaction
pcr
base
test
coinfect
virus
detect
children
thu
potenti
nosocomi
transmiss
varieti
virus
among
children
hospit
bronchiol
high
diagnost
test
potenti
influenc
cohort
clinic
manag
prevent
health
careassoci
infect
communityacquir
pneumonia
cap
import
caus
morbid
hospit
children
develop
countri
one
lead
caus
death
children
less
develop
countri
larg
number
establish
emerg
pathogen
caus
pneumonia
difficulti
determin
microbi
caus
complic
manag
pneumonia
children
addit
difficult
obtain
adequ
specimen
lower
respiratori
tract
nasopharyng
carriag
potenti
pathogen
common
healthi
children
moreov
coinfect
pathogen
common
etiolog
pneumonia
children
differ
accord
age
child
season
clinic
present
rel
contemporari
studi
etiolog
pediatr
pneumonia
studi
vari
popul
studi
case
definit
clinic
specimen
test
methodolog
number
pathogen
sought
prospect
studi
potenti
pathogen
identifi
children
pneumonia
tabl
summar
sever
recent
studi
children
hospit
cap
despit
differ
method
use
age
group
studi
overal
result
gener
similar
studi
least
potenti
pathogen
identifi
children
studi
least
viru
identifi
children
mix
viral
bacteri
infect
identifi
studi
viral
infect
common
children
year
age
viral
caus
pneumonia
import
age
group
use
pcr
increas
proport
children
cap
found
viral
infect
tsolia
et
al
studi
schoolag
children
hospit
cap
use
convent
cultur
pcr
assay
influenza
rsv
parainfluenza
adenoviru
mycoplasma
pneumonia
chlamydophila
pneumonia
pathogen
demonstr
viru
bacteri
infect
coinfect
adenoviru
present
procalcitonin
creactiv
protein
level
significantli
higher
children
bacteri
infect
sensit
test
modest
respect
specif
low
respect
associ
radiolog
descript
etiolog
remain
unclear
studi
whether
children
coinfect
virus
bacteria
sever
ill
although
clear
influenza
parainfluenza
rsv
human
metapneumoviru
adenoviru
import
caus
cap
absenc
bacteri
coinfect
role
rhinovirus
newli
describ
virus
includ
human
coronavirus
bocaviru
harder
determin
rhinovirus
common
caus
mild
upper
respiratori
ill
detect
rhinoviru
asymptomat
person
rel
common
jartti
et
al
review
studi
report
detect
virus
asymptomat
adult
children
although
particip
household
contact
ill
patient
use
convent
cultur
rhinoviru
detect
uncommon
mean
rang
use
pcr
rhinoviru
detect
frequent
mean
rang
studi
perform
sequenti
sampl
shown
pcr
posit
rel
brief
replic
mani
strain
rhinoviru
limit
higher
temperatur
thought
prevent
replic
lower
respiratori
tract
howev
recent
studi
demonstr
rhinoviru
replic
higher
temperatur
infect
lower
respiratori
tract
although
seasonand
agematch
control
subject
would
help
detect
rhinoviru
young
children
hospit
cap
substanti
higher
studi
would
expect
children
uncompl
urti
pcrbase
detect
sequenc
rhinovirus
reveal
greater
degre
genet
diverg
appreci
culturebas
detect
possibl
better
understand
virus
identifi
genotyp
greater
capac
lower
respiratori
tract
diseas
sever
diseas
three
new
coronavirus
capabl
infect
human
describ
recent
sever
acut
respiratori
syndrom
coronaviru
rapidli
identifi
outbreak
sever
respiratori
diseas
detect
china
vietnam
singapor
earli
fortun
sporad
laboratoryassoci
case
detect
sinc
contain
worldwid
outbreak
end
human
coronaviru
identifi
netherland
clearli
associ
croup
bronchiol
occasion
pneumonia
human
coronaviru
detect
adult
hong
kong
one
initi
studi
hong
kong
detect
patient
cap
studi
shown
slightli
lower
frequenc
detect
respiratori
pathogen
specimen
hospit
children
seattl
prospect
activ
surveil
studi
involv
children
year
age
nashvil
coronavirus
includ
isol
children
hospit
respiratori
diseas
thu
coronavirus
appear
signific
rel
uncommon
caus
hospit
among
children
bocaviru
first
isol
nasopharyng
aspir
specimen
children
respiratori
tract
infect
unlik
mani
respiratori
virus
singlestrand
dna
viru
famili
parvovirida
bocaviru
also
isol
stool
serum
sampl
bocaviru
frequent
detect
conjunct
pathogen
may
detect
prolong
period
thu
challeng
demonstr
clinic
import
bocaviru
detect
howev
least
studi
show
isol
bocaviru
alon
common
ill
children
control
subject
bocaviru
load
significantli
higher
patient
bocaviru
coinfect
thu
accumul
data
support
role
bocaviru
true
pathogen
determin
relev
isol
individu
patient
remain
difficult
respiratori
viral
infect
import
caus
sever
diseas
children
adult
receiv
solid
organ
hematopoiet
stem
cell
transplant
children
appear
increas
risk
infect
respiratori
virus
compar
adult
transplant
recipi
respiratori
virus
caus
sever
fatal
pneumonia
may
trigger
chronic
progress
airway
obstruct
role
rsv
influenza
viru
adenoviru
parainfluenza
virus
appreci
sever
year
reason
well
understood
season
distribut
parallel
epidemiolog
commun
infect
may
attribut
shed
visitor
staff
patient
upper
respiratori
tract
mani
outbreak
describ
transplant
unit
horizont
transmiss
recipi
stem
cell
transplant
mortal
associ
lower
respiratori
tract
infect
due
older
respiratori
virus
improv
molecular
detect
led
increas
recognit
hmpv
coronaviru
bocaviru
rhinoviru
infect
transplant
recipi
report
sever
diseas
associ
pathogen
howev
mani
unansw
question
remain
risk
factor
natur
histori
optim
manag
pathogen
accur
time
diagnosi
caus
lrti
children
potenti
benefit
includ
improv
treatment
individu
child
decreas
overal
cost
care
reduc
select
antimicrobi
organ
due
excess
antibiot
use
specif
viral
diagnosi
may
provid
reassur
parent
provid
random
trial
case
seri
examin
potenti
viral
test
improv
manag
bonner
et
al
conduct
random
trial
provid
emerg
depart
physician
result
influenza
rapid
test
febril
children
children
influenza
access
test
result
reduc
number
antibiot
prescript
order
urinalysi
urin
cultur
complet
blood
count
blood
cultur
chest
radiograph
differ
seen
among
influenza
quasirandom
trial
influenza
rapid
test
show
similar
result
analysi
includ
children
use
rapid
test
influenc
clinician
behavior
howev
among
children
test
posit
influenza
either
method
rapid
influenza
test
less
like
urinalysi
urin
cultur
complet
blood
count
order
doan
et
al
studi
children
year
age
seen
emerg
depart
fever
least
respiratori
symptom
random
direct
fluoresc
antibodi
test
respiratori
virus
routin
care
statist
signific
differ
durat
emerg
depart
stay
perform
chest
radiograph
blood
test
urin
analys
use
antibiot
prescript
group
howev
children
test
reduct
likelihood
receiv
antibiot
anoth
provid
within
week
visit
among
test
posit
viru
test
associ
median
reduct
durat
emerg
depart
stay
transplant
recipi
respiratori
infect
abil
detect
full
rang
viral
pathogen
critic
known
respiratori
viral
pathogen
sought
addit
cytomegaloviru
epstein
barr
viru
human
herpesviru
type
herp
simplex
viru
highli
sensit
multiplex
platform
offer
obviou
advantag
combin
direct
fluoresc
antibodi
test
dfa
cultur
individu
pcr
assay
nosocomi
viral
infect
impos
substanti
burden
children
hospit
pose
particular
risk
immunocompromis
children
earli
identif
allow
effect
cohort
isol
inabl
distinguish
among
multipl
viral
caus
bronchiol
mean
practic
cohort
children
syndrom
without
viral
diagnosi
expos
substanti
risk
acquir
new
viru
hospit
virusspecif
cohort
reduc
risk
largest
potenti
societ
benefit
may
come
reduct
unnecessari
use
antibiot
lrti
children
although
mani
factor
contribut
rapid
emerg
antimicrobi
resist
respiratori
tract
infect
remain
common
reason
prescrib
antibiot
cours
antibiot
add
select
pressur
clinic
interpret
detect
viru
nasopharyng
secret
child
lrti
challeng
possibl
viru
resolv
upper
respiratori
infect
caus
lower
respiratori
tract
diseas
detect
influenza
adenoviru
rsv
probabl
human
metapneumoviru
gener
assum
correl
infect
lower
respiratori
tract
coinfect
superinfect
bacteria
rare
biphas
ill
focal
consolid
chest
radiograph
elev
inflammatori
marker
increas
likelihood
bacteri
coinfect
research
need
help
determin
isol
rhinoviru
bocaviru
coronaviru
caus
pneumonia
viral
quantif
may
prove
help
determin
isol
associ
sever
diseas
preliminari
result
encourag
data
use
consist
sampl
method
need
valid
use
establish
cutoff
valu
evalu
new
diagnost
platform
enough
demonstr
new
test
correctli
identifi
presenc
larg
number
respiratori
pathogen
clinician
must
abl
interpret
posit
test
result
context
clinic
ill
determin
appropri
manag
unreason
expect
advanc
molecular
diagnost
test
abl
isol
instead
test
result
need
interpret
knowledg
epidemiolog
pathogen
pretest
probabl
infect
patient
symptom
clinic
inform
addit
epidemiolog
studi
need
establish
import
present
sever
recent
diagnos
pathogen
need
better
understand
role
multipl
infect
lrti
also
enough
demonstr
improv
diagnost
accuraci
test
must
ultim
chang
behavior
clinician
improv
patient
outcom
although
preliminari
result
aforement
trial
promis
test
studi
limit
breadth
accuraci
none
incorpor
detect
bacteri
caus
lrti
studi
need
use
newer
multiplex
platform
address
hospit
children
pneumonia
ideal
diagnost
test
abl
rapidli
identifi
viral
bacteri
pathogen
simultan
detect
antibiot
resist
financi
support
work
support
nation
institut
health
nih
p
center
diseas
control
prevent
p
p
receiv
travel
support
food
drug
administr
attend
meet
also
coinvestig
nihfund
research
scientist
idaho
technolog
coinvestig
supplement
sponsorship
articl
publish
part
supplement
entitl
workshop
molecular
diagnost
respiratori
tract
infect
food
drug
administr
infecti
diseas
societi
america
sponsor
workshop
astrazeneca
pharmaceut
bio
merieux
inc
cepheid
gilead
scienc
intellig
mdx
inc
inver
medic
innov
roch
molecular
system
provid
financi
support
sole
purpos
publish
supplement
potenti
conflict
interest
author
certifi
potenti
conflict
interest
